knowledge -WSS

knowledge

author：hotspot 2025-08-26 10:54:49 - browse：39

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Virtual care provider acquires bankrupt Pear's prescription apps

leisure time

WSS

GSK to buy asthma

Fauci’s Covid grilling leads GOP to weigh foreign research rules

New England Journal of Medicine addresses racist history, slavery

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Generative AI mines health records to identify patients’ social needs

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

leisure time

knowledge

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout LOUD podcast: live from JPM 2024

Peter Hotez and the public health issue of online harassment

Violet CEO on training clinicians to promote more inclusive care

Peter Hotez and the public health issue of online harassment

How to keep neuroscience’s past racism from being its future

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Prime Medicine, Myeloid Therapeutics clash over genome

hotspot

DeSantis can now import cheaper drugs. But will Biden get credit?

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Violet CEO on training clinicians to promote more inclusive care

New menopause drug shows promise in relief for hot flashes

Medicare drug price negotiation hasn't dried up venture capital

Idaho abortion case may prompt more restrictions in other states

focus

explore

leisure time

focus